Narcotics Destruction

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 is soliciting pharmaceutical reverse distributor services for the destruction and disposal of controlled substances and narcotics across six VA Northern California facilities. The contractor must provide DEA-compliant destruction services, including pickup, documentation, and certificates of destruction within 30 days of receipt, while maintaining web-based tracking software with VA Information Security Services Office approval. Key qualifications include possession of a valid DEA license, submission of a detailed service plan and quality control plan, and demonstration of past performance on at least three similar contracts. Evaluation will prioritize technical capability, quality control procedures, past performance history, and price, with the primary NAICS code being 562211 (Hazardous Waste Treatment and Disposal) and PSC Q517 (Pharmacy Services). The solicitation deadline is February 26, 2026 at 3:00 PM PST, following an extension announced in Amendment 0001 issued on February 24, 2026, and offerors must acknowledge receipt of the amendment to avoid rejection.

This opportunity is set aside 100% for small business concerns. The contract includes a one-year base period running from April 1, 2026 through March 31, 2027, with four one-year option periods available for renewal. Performance locations include Mather Medical Center, which requires bimonthly pickups of approximately 50 narcotics per visit, while Martinez, Chico, McClellan, Redding, and Stockton Outpatient Clinics require quarterly pickups with volumes ranging from approximately 10 narcotics at Chico to 25 at other sites. Contractor compensation will be structured as a flat monthly service fee covering representative labor, shipping, destruction fees, and software access, invoiced within 90 days of service dates. The place of performance is Mather, California, with services required to comply with Title 21 CFR and VHA Directive 1108.01.